June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
Kura Oncology (KURA) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: June 21, 2025 (07:09)
Sector: HealthcareThe share price of Kura Oncology, Inc. (KURA) now
Are you interested in Kura Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kura Oncology stock price in 2025, 2026, 2027. How much will one Kura Oncology share be worth in 2025 - 2027?
When should I take profit in Kura Oncology stock? When should I record a loss on Kura Oncology stock? What are analysts' forecasts for Kura Oncology stock? What is the future of Kura Oncology stock? We forecast Kura Oncology stock performance using neural networks based on historical data on Kura Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Kura Oncology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Kura Oncology shares. This happens once a day.
Historical and forecast chart of Kura Oncology stock
The chart below shows the historical price of Kura Oncology stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Kura Oncology stock price can be found in the table below.
Long-term forecasts by years.
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.
Kura Oncology daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun 23 | 5.90 | 5.86 | 5.94 | 1.31 |
| Jun 24 | 5.90 | 5.82 | 5.97 | 2.55 |
| Jun 25 | 5.95 | 5.92 | 6.03 | 1.87 |
| Jun 26 | 5.96 | 5.87 | 5.99 | 2.03 |
| Jun 27 | 6.04 | 5.95 | 6.12 | 2.76 |
| Jun 28 | 6.04 | 6.00 | 6.11 | 1.87 |
| Jun 29 | 6.07 | 6.02 | 6.14 | 1.93 |
| Jun 30 | 6.09 | 6.03 | 6.15 | 1.94 |
| Jul 01 | 6.13 | 6.07 | 6.19 | 2.08 |
| Jul 02 | 6.13 | 6.05 | 6.19 | 2.37 |
| Jul 03 | 6.05 | 5.96 | 6.13 | 2.82 |
| Jul 04 | 6.13 | 6.08 | 6.21 | 2.06 |
| Jul 05 | 6.22 | 6.20 | 6.32 | 1.93 |
| Jul 06 | 6.24 | 6.15 | 6.32 | 2.70 |
| Jul 07 | 6.29 | 6.20 | 6.36 | 2.45 |
| Jul 08 | 6.26 | 6.20 | 6.35 | 2.34 |
| Jul 09 | 6.34 | 6.29 | 6.37 | 1.27 |
| Jul 10 | 6.45 | 6.38 | 6.53 | 2.30 |
| Jul 11 | 6.35 | 6.29 | 6.43 | 2.32 |
| Jul 12 | 6.30 | 6.25 | 6.40 | 2.40 |
| Jul 13 | 6.25 | 6.16 | 6.34 | 2.99 |
| Jul 14 | 6.20 | 6.16 | 6.28 | 1.83 |
| Jul 15 | 6.20 | 6.13 | 6.22 | 1.50 |
| Jul 16 | 6.14 | 6.08 | 6.22 | 2.44 |
| Jul 17 | 6.13 | 6.04 | 6.19 | 2.47 |
| Jul 18 | 6.23 | 6.18 | 6.26 | 1.35 |
| Jul 19 | 6.22 | 6.13 | 6.27 | 2.25 |
| Jul 20 | 6.21 | 6.17 | 6.25 | 1.31 |
| Jul 21 | 6.12 | 6.06 | 6.17 | 1.78 |
| Jul 22 | 6.13 | 6.06 | 6.21 | 2.41 |
Kura Oncology Daily Price Targets
Kura Oncology Stock Forecast 06-23-2025.
Forecast target price for 06-23-2025: $5.90.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.292%.
Pessimistic target level: 5.86
Optimistic target level: 5.94
Kura Oncology Stock Forecast 06-24-2025.
Forecast target price for 06-24-2025: $5.90.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 2.491%.
Pessimistic target level: 5.82
Optimistic target level: 5.97
Kura Oncology Stock Forecast 06-25-2025.
Forecast target price for 06-25-2025: $5.95.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.834%.
Pessimistic target level: 5.92
Optimistic target level: 6.03
Kura Oncology Stock Forecast 06-26-2025.
Forecast target price for 06-26-2025: $5.96.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.988%.
Pessimistic target level: 5.87
Optimistic target level: 5.99
Kura Oncology Stock Forecast 06-27-2025.
Forecast target price for 06-27-2025: $6.04.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 2.688%.
Pessimistic target level: 5.95
Optimistic target level: 6.12
Kura Oncology Stock Forecast 06-28-2025.
Forecast target price for 06-28-2025: $6.04.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 1.840%.
Pessimistic target level: 6.00
Optimistic target level: 6.11
KURA (KURA) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 5.79 | 5.05 | 6.25 | 19.21 |
| Aug. | 5.78 | 5.43 | 6.22 | 12.63 |
| Sep. | 6.20 | 5.48 | 6.98 | 21.44 |
| Oct. | 6.45 | 5.93 | 7.01 | 15.49 |
| Nov. | 5.73 | 5.05 | 6.18 | 18.29 |
| Dec. | 5.27 | 5.08 | 5.85 | 13.17 |
Kura Oncology forecast for this year
Kura Oncology Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $5.78673. Pessimistic: $5.05. Optimistic: $6.25
Kura Oncology Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $5.77689. Pessimistic: $5.43. Optimistic: $6.22
Kura Oncology Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $6.19918. Pessimistic: $5.48. Optimistic: $6.98
Kura Oncology Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $6.45211. Pessimistic: $5.93. Optimistic: $7.01
Kura Oncology Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $5.72818. Pessimistic: $5.05. Optimistic: $6.18
Kura Oncology Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $5.2705. Pessimistic: $5.08. Optimistic: $5.85
Kura Oncology (KURA) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.00 | 4.65 | 5.24 | 11.20 |
| Feb | 5.24 | 4.56 | 5.64 | 19.11 |
| Mar | 5.52 | 4.84 | 5.74 | 15.71 |
| Apr | 5.48 | 4.85 | 5.99 | 18.97 |
| May | 4.99 | 4.80 | 5.63 | 14.78 |
| Jun | 4.19 | 3.66 | 4.59 | 20.18 |
| Jul | 4.78 | 4.58 | 5.39 | 14.93 |
| Aug | 5.54 | 5.24 | 6.13 | 14.46 |
| Sep | 5.51 | 5.32 | 6.24 | 14.86 |
| Oct | 6.08 | 5.72 | 6.80 | 15.82 |
| Nov | 7.12 | 6.36 | 7.89 | 19.47 |
| Dec | 6.78 | 6.24 | 7.31 | 14.66 |
Kura Oncology (KURA) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 6.62 | 5.82 | 7.35 | 20.82 |
| Feb | 6.52 | 5.94 | 6.99 | 15.05 |
| Mar | 6.91 | 6.46 | 7.45 | 13.24 |
| Apr | 7.43 | 6.64 | 8.43 | 21.28 |
| May | 6.54 | 6.06 | 7.01 | 13.62 |
| Jun | 6.69 | 6.34 | 7.25 | 12.55 |
| Jul | 6.25 | 5.74 | 6.58 | 12.76 |
| Aug | 6.26 | 5.41 | 6.61 | 18.19 |
| Sep | 6.91 | 6.09 | 7.18 | 15.22 |
| Oct | 6.97 | 6.55 | 7.74 | 15.31 |
| Nov | 6.88 | 6.52 | 7.60 | 14.17 |
| Dec | 5.77 | 5.16 | 6.27 | 17.68 |
Kura Oncology information and performance
3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA, US
Market capitalization of the Kura Oncology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KURA shares in the company outstanding by the market price of one share.
EBITDA of Kura Oncology is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Kura Oncology Stock)
Should I Buy Kura Oncology Shares in 2025 year?
Does Kura Oncology pay dividends?
Which economic sector do Kura Oncology's shares belong to?
Which other securities belong to the same sector as Kura Oncology's shares?
